Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062)
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infection
- Status
- COMPLETED
- Phase
- PHASE4
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Multiple Ascending Dose Study of MK-5160 in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-5160-002)
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab in Patients With Leptomeningeal Disease
- Status
- TERMINATED
- Phase
- PHASE2
Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging Biomarker
- Status
- COMPLETED
- Phase
- PHASE2
'Fibrosis in the Lost Hepatitis C Population - Track, Trace and Treat'
- Status
- COMPLETED
- Phase
- N/A
Personalising Anti-TNF Therapy in Crohns Disease (PANTS)
- Status
- UNKNOWN
- Phase
- N/A
A Randomized Controlled Crossover Study Comparing Sugammadex and Placebo
- Status
- COMPLETED
- Phase
- PHASE4
Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II Trial of Continuation Therapy in Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Alvimopan Use in Polytraumatized Patients
- Status
- TERMINATED
- Phase
- PHASE4
A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)
- Status
- COMPLETED
- Phase
- PHASE3